ارتباط بیان ژنی ACE و GHRL با بیماری مزمن کبد چرب: بینش‌های بالینی و متابولیک

Alavi, M., Mozafari, M. R., Ghaemi, S., Ashengroph, M., Hasanzadeh Davarani, F., & Mohammadabadi, M. (2022). Interaction of epigallocatechin gallate and quercetin with spike glycoprotein (S-glycoprotein) of SARS-CoV-2: In silico study. Biomedicines, 10(12), e3074. https://doi.org/10.3390/biomedicines10123074 

Ali, A. H., Petroski, G. F., Diaz-Arias, A. A., Al Juboori, A., Wheeler, A. A., Ganga, R. R., Pitt, J. B., Spencer, N. M., Hammoud, G. M., Rector, R. S., Parks, E. J., & Ibdah, J. A. (2021). A model incorporating serum alkaline phosphatase for prediction of liver fibrosis in adults with obesity and nonalcoholic fatty liver disease. Journal of Clinical Medicine, 10(15), 3311. https://doi.org/10.3390/jcm10153311

Amiri Roudbar, M., Mohammadabadi, M. R., Ayatollahi Mehrgardi, A., Abdollahi-Arpanahi, R., Momen, M., Morota, G., Brito Lopes, F., Gianola, D., & Rosa, G. J. M. (2020). Integration of single nucleotide variants and whole-genome DNA methylation profiles for classification of rheumatoid arthritis cases from controls. Heredity, 124(5), 658-674. https://doi.org/10.1038/s41437-020-0301-4 

Arabpour, Z., Mohammadabadi, M., & Khezri, A. (2021). The expression pattern of p32 gene in femur, humeral muscle, back muscle and back fat tissues of Kermani lambs. Agricultural Biotechnology Journal, 13(4), 183-200. https://doi.org/10.22103/jab.2022.18782.1371 

Buchynskyi, M., Oksenych, V., Kamyshna, I., Vorobets, I., Halabitska, I., & Kamyshnyi, O. (2024). Modulatory roles of AHR, FFAR2, FXR, and TGR5 gene expression in metabolic-associated fatty liver disease and COVID-19 outcomes. Viruses, 16(6), 985. https://doi.org/10.3390/v16060985

Carlier, A., Phan, F., Szpigel, A., Hajduch, E., Salem, J. E., Gautheron, J., Le Goff, W., Guérin, M., Lachkar, F., Ratziu, V., Hartemann, A., Ferré, P., Foufelle, F., & Bourron, O. (2020). Dihydroceramides in triglyceride-enriched VLDL are associated with nonalcoholic fatty liver disease severity in type 2 diabetes. Cell Reports Medicine, 1(9), 100154. https://doi.org/10.1016/j.xcrm.2020.100154

Chen, C., Zhu, Z., Mao, Y., Xu, Y., Du, J., Tang, X., & Cao, H. (2020). HbA1c may contribute to the development of non-alcoholic fatty liver disease even at normal-range levels. Bioscience Reports, 40(1), BSR20193996. https://doi.org/10.1042/BSR20193996

Choochuay, K., Kunhapan, P., Puangpetch, A., Tongsima, S., Srisawasdi, P., Sobhonslidsuk, A., Sungkanuparph, S., Biswas, M., & Sukasem, C. (2024). Associations of PNPLA3 and LEP genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virus. World Journal of Hepatology, 16(3), 366–378. https://doi.org/10.4254/wjh.v16.i3.366

Eslam, M., Sanyal, A. J., George, J., & International Consensus Panel. (2020). MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology, 158(7), 1999–2014.e1. https://doi.org/10.1053/j.gastro.2019.11.312

Hajalizadeh, Z., Dayani, O., Khezri, A., Tahmasbi, R., Mohammadabadi, M., Solodka, T., Kalashnyk, O., Afanasenko, V., & Babenko, O. (2021). Expression of calpastatin gene in Kermani sheep using real-time PCR. Journal of Livestock Science and Technologies, 9(2), 51-57. https://doi.org/10.22103/jlst.2021.18165.1381

Heidarpour, F., Mohammadabadi, M. R., Zaidul, I. S. M., Maherani, B., & Saari, N. (2011). Use of prebiotics in oral delivery of bioactive compounds: A nanotechnology perspective. Pharmazie, 66(5), 319-324. https://pubmed.ncbi.nlm.nih.gov/21699064/

Hou, X., Guan, Y., Tang, Y., Song, A., Zhao, J., Ren, L., Chen, S., Wei, L., Ma, H., & Song, G. (2021). A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test. Lipids in Health and Disease, 20(1), 54. https://doi.org/10.1186/s12944-021-01483-z

Huang, C., Seah, J. J., Tan, C. K., Kam, J. W., Tan, J., Teo, E. K., Kwek, A., Wong, Y. J., Tan, M., Ang, T. L., & Kumar, R. (2021). Modified AST to platelet ratio index improves APRI and better predicts advanced fibrosis and liver cirrhosis in patients with non-alcoholic fatty liver disease. Clinical Research in Hepatology and Gastroenterology, 45(4), 101528. https://doi.org/10.1016/j.clinre.2020.08.006

Imamura, Y., Mawatari, S., Oda, K., Kumagai, K., Hiramine, Y., Saishoji, A., Kakihara, A., Nakahara, M., Oku, M., Hosoyamada, K., Kanmura, S., Moriuchi, A., Miyahara, H., & Ido, A. (2021). Changes in body composition and low blood urea nitrogen level related to an increase in the prevalence of fatty liver over 20 years: A cross-sectional study. Hepatology Research, 51(5), 570–579. https://doi.org/10.1111/hepr.13631

Khabiri, A., Toroghi, R., Mohammadabadi, M., & Tabatabaeizadeh, S. E. (2023). Introduction of a Newcastle disease virus challenge strain (sub-genotype VII.1.1) isolated in Iran. Veterinary Research Forum, 14(4), 221. https://doi.org/10.30466/vrf.2022.548152.3373

Kong, L., Chen, J., Ji, X., Qin, Q., Yang, H., Liu, D., Li, D., & Sun, M. (2021). Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance. Journal of Experimental & Clinical Cancer Research, 40(1), 18. https://doi.org/10.1186/s13046-020-01782-w

Li, Z., Zhang, B., Liu, Q., Tao, Z., Ding, L., Guo, B., Zhang, E., Zhang, H., Meng, Z., Guo, S., Chen, Y., Peng, J., Li, J., Wang, C., Huang, Y., Xu, H., & Wu, Y. (2023). Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease. EBioMedicine, 90, 104543. https://doi.org/10.1016/j.ebiom.2023.104543

Lin, H., Yip, T. C., Zhang, X., Li, G., Tse, Y. K., Hui, V. W., Liang, L. Y., Lai, J. C., Chan, S. L., Chan, H. L., Wong, G. L., & Wong, V. W. (2023). Age and the relative importance of liver-related deaths in nonalcoholic fatty liver disease. Hepatology, 77(2), 573–584. https://doi.org/10.1002/hep.32633

Liu, H., He, B., Hu, W., Liu, K., Dai, Y., Zhang, D., & Wang, H. (2021). Prenatal dexamethasone exposure induces nonalcoholic fatty liver disease in male rat offspring via the miR-122/YY1/ACE2-MAS1 pathway. Biochemical Pharmacology, 185, 114420. https://doi.org/10.1016/j.bcp.2021.114420

Liu, J., Peng, H., Wang, C., Wang, Y., Wang, R., Liu, J., Zhou, T., & Yao, S. (2023). Correlation between the severity of metabolic dysfunction-associated fatty liver disease and serum uric acid to serum creatinine ratio. International Journal of Endocrinology, 2023, 6928117. https://doi.org/10.1155/2023/6928117

Lu, S., Xie, Q., Kuang, M., Hu, C., Li, X., Yang, H., Sheng, G., Xie, G., & Zou, Y. (2023). Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: Evidence from a mediation analysis. Journal of Translational Medicine, 21(1), 192. https://doi.org/10.1186/s12967-023-04047-0

Ma, X., Liu, S., Zhang, J., Dong, M., Wang, Y., Wang, M., & Xin, Y. (2020). Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: A systematic review and meta-analysis. BMC Gastroenterology, 20(1), 10. https://doi.org/10.1186/s12876-020-1165-z

Mocciaro, G., Allison, M., Jenkins, B., Azzu, V., Huang-Doran, I., Herrera-Marcos, L. V., Hall, Z., Murgia, A., Susan, D., Frontini, M., Vidal-Puig, A., Koulman, A., Griffin, J. L., & Vacca, M. (2023). Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL). Molecular Metabolism, 73, 101728. https://doi.org/10.1016/j.molmet.2023.101728

Mohamadinejad, F., Mohammadabadi, M., Roudbari, Z., Eskandarynasab Siahkouhi, S., Babenko, O., Klopenko, N., Borshch, O., Starostenko, I., Kalashnyk, O., & Assadi Soumeh, E. (2024). Analysis of liver transcriptome data to identify the genes affecting lipid metabolism during the embryonic and hatching periods in ROSS breeder broilers. Journal of Livestock Science and Technologies, 12(2), 61-67. https://doi.org/10.22103/jlst.2024.23814.1554

Mohammadabadi, M., & Asadollahpour Nanaei, H. (2021). Leptin gene expression in Raini Cashmere goat using Real Time PCR. Agricultural Biotechnology Journal, 13(1), 197-214. https://doi.org/10.22103/jab.2021.17334.1305 

Mohammadabadi, M., Afsharmanesh, M., Khezri, A., Kheyrodin, H., Babenko, O. I., Borshch, O., Kalashnyk, O., Nechyporenko, O., Afanasenko, V., Slynko, V., & Usenko, S. (2025). Effect of mealworm on GBP4L gene expression in the spleen tissue of Ross broiler chickens. Agricultural Biotechnology Journal, 17(2), 343–360. https://doi.org/10.22103/jab.2025.25277.1714

Mohammadabadi, M., Babenko, I., Borshch, O., Kalashnyk, O., Ievstafiieva, Y., & Buchkovska, V. (2024). Measuring the relative expression pattern of the UCP2 gene in different tissues of the Raini Cashmere goat. Agricultural Biotechnology Journal, 16(3), 317-332. https://doi.org/10.22103/jab.2024.24337.1627  

Mohammadabadi, M., Golkar, A., & Askari Hesni, M. (2023). The effect of fennel (Foeniculum vulgare) on insulin-like growth factor 1 gene expression in the rumen tissue of Kermani sheep. Agricultural Biotechnology Journal, 15(4), 239-256. https://doi.org/10.22103/jab.2023.22647.1530

Mohammadabadi, M., Kheyrodin, H., Latifi, A., & Babenko Ivanivna, O. (2022a). mRNA expression profile of DNAH1 gene in testis tissue of Raini Cashmere goat. Agricultural Biotechnology Journal, 14(3), 243-256. https://doi.org/10.22103/jab.2022.20199.1428

Mohammadabadi, M., Shaban Jorjandy, D., Arabpoor Raghabadi, Z., Abareghi, F., Sasan, H. A., & Bordbar, F. (2022b). The role of fennel on DLK1 gene expression in sheep heart tissue. Agricultural Biotechnology Journal, 14(2), 155-170. https://doi.org/10.22103/jab.2022.19402.1399

Noori, A. N., Behzadi, M. R. B., & Mohammadabadi, M. R. (2017). Expression pattern of Rheb gene in Jabal Barez Red goat. The Indian Journal of Animal Sciences, 87(11), 1375–1378. https://doi.org/10.56093/ijans.v87i11.75890 

Quek, J., Chan, K. E., Wong, Z. Y., Tan, C., Tan, B., Lim, W. H., Tan, D. J. H., Tang, A. S. P., Tay, P., Xiao, J., Yong, J. N., Zeng, R. W., Chew, N. W. S., Nah, B., Kulkarni, A., Siddiqui, M. S., Dan, Y. Y., Wong, V. W., Sanyal, A. J., … Ng, C. H. (2023). Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: A systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 8(1), 20–30. https://doi.org/10.1016/S2468-1253(22)00317-X

Rajapaksha, I. G., Gunarathne, L. S., Asadi, K., Laybutt, R., Andrikopoulous, S., Alexander, I. E., Watt, M. J., Angus, P. W., & Herath, C. B. (2022). Angiotensin converting enzyme-2 therapy improves liver fibrosis and glycemic control in diabetic mice with fatty liver. Hepatology Communications, 6(5), 1056–1072. https://doi.org/10.1002/hep4.1884

Rezamand, G., Mahmoudi, T., Tabaeian, S. P., Farahani, H., Shahinmehr, F., Nobakht, H., Dabiri, R., Asadi, A., Mansour-Ghanaei, F., & Zali, M. R. (2021). The "GG" genotype of rs26802 variant in the ghrelin gene is a potential protective factor against nonalcoholic fatty liver disease. Physiological International, 108(3), 342–352. https://doi.org/10.1556/2060.2021.00183

Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., Arrese, M., Bataller, R., Beuers, U., Boursier, J., Bugianesi, E., Byrne, C. D., Castro Narro, G. E., Chowdhury, A., Cortez-Pinto, H., … Newsome, P. N. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 78(6), 1966–1986. https://doi.org/10.1097/HEP.0000000000000520

Roudbar, M.A., Mohammadabadi, M., & Salmani, V. (2015). Epigenetics: A new challenge in animal breeding. Genetics in the Third Millennium, 12(4), 3900–3914.

Safaei, S. M. H., Dadpasand, M., Mohammadabadi, M., Atashi, H., Stavetska, R., Klopenko, N., & Kalashnyk, O. (2022). An Origanum majorana leaf diet influences Myogenin gene expression, performance, and carcass characteristics in lambs. Animals, 13(1), 14. https://doi.org/10.3390/ani13010014

Safaei, S. M. H., Mohammadabadi, M., Moradi, B., Kalashnyk, O., Klopenko, N., Babenko, O., Borshch, O. O., & Afanasenko, V. (2024). Role of fennel (Foeniculum vulgare) seed powder in increasing testosterone and IGF1 gene expression in the testis of lamb. Gene Expression, 23(2), 98-105. https://doi.org/10.14218/GE.2023.00020

Shahsavari, M., Mohammadabadi, M., Khezri, A., Borshch, O., Babenko, O., Kalashnyk, O., Afanasenko, V., & Kondratiuk, V. (2022). Effect of fennel (Foeniculum vulgare) seed powder consumption on insulin-like growth factor 1 gene expression in the liver tissue of growing lambs. Gene Expression, 21(2), 21-26. https://doi.org/10.14218/GE.2022.00017

Shiha, G., Korenjak, M., Eskridge, W., Casanovas, T., Velez-Moller, P., Högström, S., Richardson, B., Munoz, C., Sigurðardóttir, S., Coulibaly, A., Milan, M., Bautista, F., Leung, N. W. Y., Mooney, V., Obekpa, S., Bech, E., Polavarapu, N., Hamed, A. E., Radiani, T., … Eslam, M. (2021). Redefining fatty liver disease: An international patient perspective. The Lancet Gastroenterology & Hepatology, 6(1), 73–79. https://doi.org/10.1016/S2468-1253(20)30294-6

Shokri, S., Khezri, A., Mohammadabadi, M., & Kheyrodin, H. (2023). The expression of MYH7 gene in femur, humeral muscle and back muscle tissues of fattening lambs of the Kermani breed. Agricultural Biotechnology Journal, 15(2), 217-236. https://doi.org/10.22103/jab.2023.21524.1486

Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., Sirlin, C. B., Talukdar, S., Hellerstein, M. K., & Klein, S. (2020). Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. Journal of Clinical Investigation, 130(3), 1453–1460. https://doi.org/10.1172/JCI134165

Sveinbjornsson, G., Ulfarsson, M. O., Thorolfsdottir, R. B., Jonsson, B. A., Einarsson, E., Gunnlaugsson, G., Rognvaldsson, S., Arnar, D. O., Baldvinsson, M., Bjarnason, R. G., DBDS Genomic Consortium, Eiriksdottir, T., Erikstrup, C., Ferkingstad, E., Halldorsson, G. H., Helgason, H., Helgadottir, A., Hindhede, L., Hjorleifsson, G., … Stefansson, K. (2022). Multiomics study of nonalcoholic fatty liver disease. Nature Genetics, 54(11), 1652–1663. https://doi.org/10.1038/s41588-022-01199-5

Tabaeian, S. P., Mahmoudi, T., Sabzikarian, M., Rezamand, G., Dabiri, R., Nobakht, H., Asadi, A., Farahani, H., Mansour-Ghanaei, F., & Zali, M. R. (2021). The Leu72Met (rs696217 G>T) polymorphism of the ghrelin gene might be a protective factor for nonalcoholic fatty liver disease. Journal of Gastrointestinal and Liver Diseases, 30(2), 233–239. https://doi.org/10.15403/jgld-2703

Teng, M. L., Ng, C. H., Huang, D. Q., Chan, K. E., Tan, D. J., Lim, W. H., Yang, J. D., Tan, E., & Muthiah, M. D. (2023). Global incidence and prevalence of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology, 29(Suppl), S32–S42. https://doi.org/10.3350/cmh.2022.0365

Tuero, C., Becerril, S., Ezquerro, S., Neira, G., Frühbeck, G., & Rodríguez, A. (2023). Molecular and cellular mechanisms underlying the hepatoprotective role of ghrelin against NAFLD progression. Journal of Physiology and Biochemistry, 79(4), 833–849. https://doi.org/10.1007/s13105-022-00933-1

Wang, Z., Du, H., Zhao, Y., Ren, Y., Ma, C., Chen, H., Li, M., Tian, J., Xue, C., Long, G., Xu, M., & Jiang, Y. (2023). Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials. Frontiers in Endocrinology, 14, 1111430. https://doi.org/10.3389/fendo.2023.1111430

Yang, M., Ma, X., Xuan, X., Deng, H., Chen, Q., & Yuan, L. (2020). Liraglutide attenuates non-alcoholic fatty liver disease in mice by regulating the local renin-angiotensin system. Frontiers in Pharmacology, 11, 432. https://doi.org/10.3389/fphar.2020.00432

Yang, Y., Cai, J., Yang, X., Wang, K., Sun, K., Yang, Z., Zhang, L., Yang, L., Gu, C., Huang, X., Wang, Z., & Zhu, X. (2022). Dysregulated m6A modification promotes lipogenesis and development of non-alcoholic fatty liver disease and hepatocellular carcinoma. Molecular Therapy, 30(6), 2342–2353. https://doi.org/10.1016/j.ymthe.2022.02.021

Zhang, C., Xu, Q., Xu, C., Yang, K., Xia, T., Hasi, W., Hao, M., & Kuang, H. (2024). Sex differences in the association between AST/ALT and incidence of type 2 diabetes in Japanese patients with nonalcoholic fatty liver disease: A retrospective cohort study. Endocrine Research, 49(1), 1–11. https://doi.org/10.1080/07435800.2023.2262034